← Back to Search

Laddr for Binge Eating

N/A
Waitlist Available
Led By Russell A Poldrack, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 days
Awards & highlights

Study Summary

This study is evaluating whether self-regulation can be manipulated to help individuals with binge eating disorder.

Eligible Conditions
  • Binge Eating
  • Behavior
  • Smoking

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Binge Eating Episodes - Loss of Control
Binge Eating Episodes - Overeating
Number of Cigarettes Smoked Per Day

Trial Design

2Treatment groups
Experimental Treatment
Group I: Smoking GroupExperimental Treatment1 Intervention
All participants in the study will be invited to use Laddr, described in the intervention section.
Group II: Binge Eating GroupExperimental Treatment1 Intervention
All participants in the study will be invited to use Laddr, described in the intervention section.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Laddr
2018
N/A
~1740

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,341,264 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,785 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,469 Previous Clinical Trials
2,619,318 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~16 spots leftby Apr 2025